Allan Cripps
12Patents
2h-index
10Co-inventors
47Inventor score
Filing activity: Apr 30, 1992 → Mar 14, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5420014A | Rapid in vitro test for helicobacter pylori using saliva | Physics | 18 | Expired |
| US6068985A | In vitro test for Helicobacter pylori | Physics | 17 | Expired |
| US6284477A | Diagnostic method of use of OMP26 antigen from Haemophilus influenzae | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6245338A | OMP26 antigen from Haemophilus influenzae | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6254875A | Methods for use of OMP26 from Haemophilus influenzae | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7557185B2 | Moraxella catarrhalis proteins | Human Necessities | 0 | Expired |
| US5882649A | Oral vaccine comprising antigen surface-associated with red blood cells | Chemistry; Metallurgy | 0 | Expired |
| US7371394B2 | Antigenic composition of a Pseudomonas aeruginosa protein | Emerging Cross-Sectional Technologies | 0 | Active |
| US7517533B2 | Pseudomonas aeruginosa antigens | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6313281A | Nucleic acid encoding OMP26 antigen from Haemophilus influenzae | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9498525B2 | Treatment or prophylaxis of asthma | Emerging Cross-Sectional Technologies | 0 | Active |
| US7029684B1 | Antigenic composition of a Pseudomonas aeruginosa | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.